Personalised Medicine and Diagnostics Europe 2011
Innovate in an era of cost-effectiveness: Realise the value of personalised medicine Discover how...
King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY
King Pharmaceuticals, Inc. and Pain Therapeutics, Inc. announced that King has resubmitted a New Drug...
Sanofi-aventis Acquires from Ascendis Pharma Worldwide Rights on Drug-Delivery
Sanofi-aventis and Ascendis Pharma (Ascendis) announced a global licensing and patent transfer agreement on Ascendis’...
Bristol-Myers Squibb Company and Pfizer Inc.announced that the ADVANCE-3 study results
Bristol-Myers Squibb Company and Pfizer Inc.announced that the ADVANCE-3 study results, published in The New...
Novartis drug Tasigna approved in Japan for treatment of patients with newly diagnosed Ph+...
Novartis has received approval from Japan's Ministry of Health, Labour and Welfare to offer Tasigna®...
Lilly Announces Completion of Avid Acquisition and FDA Priority Review for florbetapir
Eli Lilly and Company announced that it has completed the acquisition of Avid Radiopharmaceuticals, Inc.,...
Merck KGaA and sanofi-aventis Sign Agreement to Jointly Investigate Novel Combinations Against Cancer
Merck KGaA announced today that it has signed a worldwide research and development agreement with...
Malaria Vaccine Initiative, Merck and NYU Langone Medical Center Collaborate to Research Potential Malaria...
Development of a vaccine to prevent the malaria parasite from entering the human liver is...
New subgroup analysis of the LUX-Lung 1 trial suggests benefit from afatinib in lung...
New data to be presented show that afatinib (BIBW 2992) leads to a significant four-fold...
The R and D Leaders Band Together at Discovery Summit 2011 to Uncover Innovative...
The Discovery Summit 2011, presented by marcus evans, will be taking place from 21-23 March...
